Filters:
Investigator: Anne Longo1 Projects | 1 Researchers | $5,609,700 Invested
2024
PharmatrophiX
Anne Longo, BA
Phase 2b/3 trial of LM11A-31-BHS for Alzheimer's Disease
Anne Longo, BA
Phase 2b/3 trial of LM11A-31-BHS for Alzheimer's Disease